A new study suggest that drop-offs in compliance with diabetes medication might negatively affect survival and could therefore partly explain the established higher cancer mortality seen among diabetes patients with worse glycemic control, according to the Netherlands Comprehensive Cancer Organization. Via Medscape Medical News. Posted January 29, 2015.
–Alanna McCatty
